Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

gut microbiome

- PMLiVE

ROAD Comms wins antimicrobial resistance account

Selected by GAMA Healthcare to create infection control campaign

- PMLiVE

The AMR threat

The scale of the antimicrobial resistance challenge

Roche - Basel

Roche drops superbug partnership with Polyphor

But adds inflammation research agreement with Proximagen

- PMLiVE

Sharing knowledge to combat emerging threats

'One health' advocates say closer cooperation between human and animal medicine firms could offer new solution

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

- PMLiVE

Call for closer ties between pharma and animal health

One Health conference hears how joint workingcould benefit both sectors

- PMLiVE

FDA backs Cubist’s antibiotic Zerbaxa

Combination cephalosporin and beta lactamase inhibitor wins US approval

The impending threat of antibiotic resistance

Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

Xellia forms scientific advisory board

Will further progress on innovative anti-infectives

Can Cinderella save us?

Antibiotic resistance to lead to millions of deaths

UK publishes first progress report for antimicrobial resistance strategy

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

Can Cinderella save us?

NICE wants responsible use of antibiotics in pneumonia

Drugs often prescribed to wrong patients

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links